Biodexa Pharmaceuticals plc American Depositary Shs
BDRX
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$2.16 – $2.32
Volume2,720
Market cap$1M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for BDRX.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for BDRX.
Recent news
Company coverage with links to the original publishers.
Biodexa Pharmaceuticals announced a 1-for-5 reverse ADR split, effective April 6, 2026, to bring its ADR price into compliance with Nasdaq's $1.00 minimum bid price requirement. The ratio change will convert every 5 old ADRs into 1 new ADR, with fractional shares sold and proceeds distributed to holders.
Biodexa Pharmaceuticals Plc reported updated data on a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma, with two out of four patients in the study now deceased.
Biodexa Pharmaceuticals Plc reported updated data on a Phase 1 study of its drug MX110 in the treatment of recurrent glioblastoma, with two out of four patients in the study now deceased.
Ericsson reported better-than-expected Q2 sales and issued guidance, causing its shares to rise in pre-market trading. Several other stocks also saw significant pre-market movement, both positive and negative.
ConAgra Brands reported weaker-than-expected Q4 sales and issued FY25 EPS guidance below estimates, causing its shares to decline. Other notable movers include Kazia Therapeutics, Biodexa Pharmaceuticals, and Volcon, which saw significant gains, while Delta Air Lines, American Airlines, and United Airlines declined.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.